Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: THE CORPORATION OF MERCER UNIVERSITY
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-09-22 to 2024-09-29
Current total value of award: $119006
Description: IN VITRO TESTS TO SUPPORT BIOEQUIVALENCE DETERMINATION WHEN GENERIC DERMATOLOGICAL FORMULATION HAS DIFFERENCES FROM THE BRAND PRODUCT FORMULATION